Published in Antimicrob Agents Chemother on September 01, 1981
Multidrug-resistant Mycobacterium tuberculosis: molecular perspectives. Emerg Infect Dis (1998) 3.05
Inhibition of synthesis of arabinogalactan by ethambutol in Mycobacterium smegmatis. Antimicrob Agents Chemother (1989) 2.68
Biogenesis of the mycobacterial cell wall and the site of action of ethambutol. Antimicrob Agents Chemother (1995) 2.17
High-performance liquid chromatography analysis of mycolic acids as an aid in laboratory identification of Rhodococcus and Nocardia species. J Clin Microbiol (1987) 1.95
Enhancement of drug susceptibility of Mycobacterium avium by inhibitors of cell envelope synthesis. Antimicrob Agents Chemother (1990) 1.72
Recognition of multiple effects of ethambutol on metabolism of mycobacterial cell envelope. Antimicrob Agents Chemother (1995) 1.61
Rapid colorimetric method for testing susceptibility of Mycobacterium tuberculosis to isoniazid and rifampin in liquid cultures. J Clin Microbiol (2003) 1.31
Widespread abundance of functional bacterial amyloid in mycolata and other gram-positive bacteria. Appl Environ Microbiol (2009) 1.05
Mycobacterium tuberculosis embB codon 306 mutations confer moderately increased resistance to ethambutol in vitro and in vivo. Antimicrob Agents Chemother (2011) 1.01
Oleoyl coenzyme A regulates interaction of transcriptional regulator RaaS (Rv1219c) with DNA in mycobacteria. J Biol Chem (2014) 0.76
Visualization of mycobacterial membrane dynamics in live cells. J Am Chem Soc (2017) 0.75
Treatment of pulmonary disease caused by opportunist mycobacteria. Thorax (1989) 0.75
Tolerant response of Streptococcus sanguis to beta-lactams and other cell wall inhibitors. Antimicrob Agents Chemother (1977) 3.17
Inhibition by ethambutol of mycolic acid transfer into the cell wall of Mycobacterium smegmatis. Antimicrob Agents Chemother (1979) 2.24
Effect of ethambutol on the viable cell count in Mycobacterium smegmatis. Antimicrob Agents Chemother (1977) 1.72
Effects of ethambutol on phospholipid metabolism in Mycobacterium smegmatis. Antimicrob Agents Chemother (1981) 1.47
Isolation, characterization, and function of 6-mycolyl-6'-acetyltrehalose in the H37Ra strain of Myocobacterium tuberculosis. Biochemistry (1976) 1.39
Chemical characterization of ethambutol binding to Mycobacterium smegmatis. Antimicrob Agents Chemother (1974) 1.01
Turnover of acylglucose, acyltrehalose and free trehalose during growth of Mycobacterium smegmatis on glucose. J Gen Microbiol (1972) 0.93
An outbreak of multidrug-resistant tuberculosis among hospitalized patients with the acquired immunodeficiency syndrome. N Engl J Med (1992) 18.11
The emergence of drug-resistant tuberculosis in New York City. N Engl J Med (1993) 12.71
Identification of mycobacteria by high-performance liquid chromatography. J Clin Microbiol (1991) 7.27
Identification of major slowly growing pathogenic mycobacteria and Mycobacterium gordonae by high-performance liquid chromatography of their mycolic acids. J Clin Microbiol (1988) 6.42
In vitro activities of U-100592 and U-100766, novel oxazolidinone antibacterial agents. Antimicrob Agents Chemother (1996) 5.08
Role of the major antigen of Mycobacterium tuberculosis in cell wall biogenesis. Science (1997) 4.96
Rapid drug-susceptibility testing of Mycobacterium tuberculosis. Am Rev Respir Dis (1981) 4.77
Effect of isoniazid on the in vivo mycolic acid synthesis, cell growth, and viability of Mycobacterium tuberculosis. Antimicrob Agents Chemother (1972) 4.64
Studies on the electron transfer system. LXVII. Polyacrylamide gel electrophoresis of the mitochondrial electron transfer complexes. Arch Biochem Biophys (1966) 3.68
Lipid A-like molecules that antagonize the effects of endotoxins on human monocytes. J Biol Chem (1991) 3.41
Separation of Mycobacterium bovis BCG from Mycobacterium tuberculosis and Mycobacterium bovis by using high-performance liquid chromatography of mycolic acids. J Clin Microbiol (1992) 3.36
High-performance liquid chromatography patterns of mycolic acids as criteria for identification of Mycobacterium chelonae, Mycobacterium fortuitum, and Mycobacterium smegmatis. J Clin Microbiol (1990) 3.27
Transmission of multidrug-resistant Mycobacterium tuberculosis among persons with human immunodeficiency virus infection in an urban hospital: epidemiologic and restriction fragment length polymorphism analysis. J Infect Dis (1993) 3.16
Identification of Mycobacterium avium complex strains and some similar species by high-performance liquid chromatography. J Clin Microbiol (1992) 3.03
Mycobacterium celatum sp. nov. Int J Syst Bacteriol (1993) 2.97
Site of inhibitory action of isoniazid in the synthesis of mycolic acids in Mycobacterium tuberculosis. J Lipid Res (1975) 2.71
Inhibition of synthesis of arabinogalactan by ethambutol in Mycobacterium smegmatis. Antimicrob Agents Chemother (1989) 2.68
Isolation and characterization of a unique group of slowly growing mycobacteria: description of Mycobacterium lentiflavum sp. nov. J Clin Microbiol (1996) 2.66
High-performance liquid chromatography of mycolic acids as a tool in the identification of Corynebacterium, Nocardia, Rhodococcus, and Mycobacterium species. J Clin Microbiol (1986) 2.51
Multidrug-resistant tuberculosis in the New York State prison system, 1990-1991. J Infect Dis (1994) 2.45
Improved method for testing susceptibility of Mycobacterium tuberculosis to pyrazinamide. J Clin Microbiol (1982) 2.44
Fatty acyl derivatives of glucosamine 1-phosphate in Escherichia coli and their relation to lipid A. Complete structure of A diacyl GlcN-1-P found in a phosphatidylglycerol-deficient mutant. J Biol Chem (1983) 2.43
Clinical significance, biochemical features, and susceptibility patterns of sporadic isolates of the Mycobacterium chelonae-like organism. J Clin Microbiol (1993) 2.40
Purification and structural determination of nontoxic lipid A obtained from the lipopolysaccharide of Salmonella typhimurium. J Biol Chem (1982) 2.33
Susceptibility of Mycobacterium tuberculosis to pyrazinamide and its relationship to pyrazinamidase activity. Antimicrob Agents Chemother (1983) 2.25
Inhibition by ethambutol of mycolic acid transfer into the cell wall of Mycobacterium smegmatis. Antimicrob Agents Chemother (1979) 2.24
Inflammatory bowel disease-like enteritis and caecitis in a senescence accelerated mouse P1/Yit strain. Gut (1998) 2.20
Absence of lipopolysaccharide in the Lyme disease spirochete, Borrelia burgdorferi. Infect Immun (1987) 2.15
The novel peptide apelin lowers blood pressure via a nitric oxide-dependent mechanism. Regul Pept (2001) 2.07
NACP, a presynaptic protein, immunoreactivity in Lewy bodies in Parkinson's disease. Neurosci Lett (1997) 2.01
High-performance liquid chromatography analysis of mycolic acids as an aid in laboratory identification of Rhodococcus and Nocardia species. J Clin Microbiol (1987) 1.95
The inflammatory cytokine response to Chlamydia trachomatis infection is endotoxin mediated. Infect Immun (1995) 1.94
In vitro susceptibility of Mycobacterium avium complex and Mycobacterium tuberculosis strains to a spiro-piperidyl rifamycin. Am Rev Respir Dis (1982) 1.92
Differential identification of mycobacteria. I. Tests on catalase activity. Am Rev Respir Dis (1966) 1.89
Influence of fine structure of lipid A on Limulus amebocyte lysate clotting and toxic activities. Infect Immun (1984) 1.89
Laboratory aspects of "Mycobacterium genavense," a proposed species isolated from AIDS patients. J Clin Microbiol (1992) 1.82
Rapid identification of mycolic acid patterns of mycobacteria by high-performance liquid chromatography using pattern recognition software and a Mycobacterium library. J Clin Microbiol (1994) 1.80
Characterization of the purified components of a new homologous series of alpha-mycolic acids from Mycobacterium tuberculosis H37Ra. J Biol Chem (1978) 1.80
Fortimicins A and B, new aminoglycoside antibiotics. I. Producing organism, fermentation and biological properties of fortimicins. J Antibiot (Tokyo) (1977) 1.74
Prostaglandin E2 stimulates aromatase expression in endometriosis-derived stromal cells. J Clin Endocrinol Metab (1997) 1.73
Effect of ethambutol on the viable cell count in Mycobacterium smegmatis. Antimicrob Agents Chemother (1977) 1.72
Separation and characterization of toxic and nontoxic forms of lipid A. Rev Infect Dis (1984) 1.71
Chronic tenosynovitis of the hand due to Mycobacterium nonchromogenicum: use of high-performance liquid chromatography for identification of isolates. Rev Infect Dis (1992) 1.70
Complete structure of lipid A obtained from the lipopolysaccharides of the heptoseless mutant of Salmonella typhimurium. J Biol Chem (1983) 1.67
Isolation and characterization of eight lipid A precursors from a 3-deoxy-D-manno-octylosonic acid-deficient mutant of Salmonella typhimurium. J Biol Chem (1985) 1.67
The role of surface in the biological activities of trehalose 6,6'-dimycolate. Surface properties and development of a model system. J Biol Chem (1981) 1.66
Position of ester groups in the lipid A backbone of lipopolysaccharides obtained from Salmonella typhimurium. J Biol Chem (1983) 1.57
Infection and disease among contacts of tuberculosis cases with drug-resistant and drug-susceptible bacilli. Am Rev Respir Dis (1985) 1.56
Identification of a novel oxazolidinone (U-100480) with potent antimycobacterial activity. J Med Chem (1996) 1.54
Molecular requirements for B-lymphocyte activation by Escherichia coli lipopolysaccharide. Proc Natl Acad Sci U S A (1983) 1.51
Effects of ethambutol on phospholipid metabolism in Mycobacterium smegmatis. Antimicrob Agents Chemother (1981) 1.47
Diphosphoryl lipid A obtained from the nontoxic lipopolysaccharide of Rhodopseudomonas sphaeroides is an endotoxin antagonist in mice. Infect Immun (1991) 1.46
Encapsulation of hydrophilic and lipophilic drugs in PLGA nanoparticles by the nanoprecipitation method. Drug Dev Ind Pharm (1999) 1.46
Location of polar substituents and fatty acyl chains on lipid A precursors from a 3-deoxy-D-manno-octulosonic acid-deficient mutant of Salmonella typhimurium. Studies by 1H, 13C, and 31P nuclear magnetic resonance. J Biol Chem (1985) 1.46
Isolation, characterization, and function of 6-mycolyl-6'-acetyltrehalose in the H37Ra strain of Myocobacterium tuberculosis. Biochemistry (1976) 1.39
Identification of the apparent carrier in mycolic acid synthesis. Proc Natl Acad Sci U S A (1994) 1.39
Deficient 17beta-hydroxysteroid dehydrogenase type 2 expression in endometriosis: failure to metabolize 17beta-estradiol. J Clin Endocrinol Metab (1998) 1.38
Monophosphoryl lipid A obtained from lipopolysaccharides of Salmonella minnesota R595. Purification of the dimethyl derivative by high performance liquid chromatography and complete structural determination. J Biol Chem (1985) 1.37
Location of fatty acids in lipid A obtained from lipopolysaccharide of Rhodopseudomonas sphaeroides ATCC 17023. J Biol Chem (1988) 1.36
Decreased bone mass and increased bone turnover with valproate therapy in adults with epilepsy. Neurology (2001) 1.35
Enzymatic synthesis of mannosyl-1-phosphoryl-decaprenol by a cell-free system of Mycobacterium tuberculosis. J Biol Chem (1970) 1.34
Lipid A and immunotherapy. Rev Infect Dis (1984) 1.29
Differential identification of Mycobacteria. V. The tellurite reduction test. Am Rev Respir Dis (1969) 1.29
A continuing survey of tuberculosis primary drug resistance in the United States: March 1975 to November 1977. A United States Public Health Service cooperative study. Am Rev Respir Dis (1978) 1.25
Diphosphoryl lipid A derived from lipopolysaccharide (LPS) of Rhodopseudomonas sphaeroides inhibits activation of 70Z/3 cells by LPS. Infect Immun (1991) 1.23
Dynamic behavior of bubbles during extracorporeal shock-wave lithotripsy. Ultrasound Med Biol (1998) 1.22
Susceptibility of mycobacterial D-alanyl-D-alanine synthetase to D-cycloserine. Am Rev Respir Dis (1969) 1.21
Drug-resistant tuberculosis. Am Rev Respir Dis (1991) 1.20
Relationship between the uptake of isoniazid and its action on in vivo mycolic acid synthesis in Mycobacterium tuberculosis. Antimicrob Agents Chemother (1972) 1.20
Clinical and epidemiologic characteristics of Mycobacterium haemophilum, an emerging pathogen in immunocompromised patients. Ann Intern Med (1994) 1.20
The effectiveness of an immobilization device in conformal radiotherapy for lung tumor: reduction of respiratory tumor movement and evaluation of the daily setup accuracy. Int J Radiat Oncol Biol Phys (2001) 1.19
miR-148a is an androgen-responsive microRNA that promotes LNCaP prostate cell growth by repressing its target CAND1 expression. Prostate Cancer Prostatic Dis (2010) 1.18
Occurrence and distribution of Vibrio spp., Listonella spp., and Clostridium botulinum in the Seto Inland Sea of Japan. Appl Environ Microbiol (1989) 1.17
Sex-dependent expression of a transcription factor, Ad4BP, regulating steroidogenic P-450 genes in the gonads during prenatal and postnatal rat development. Development (1994) 1.17
Absorption of insulin from pluronic F-127 gels following subcutaneous administration in rats. Int J Pharm (1999) 1.16
Estrogen biosynthesis in endometriosis: molecular basis and clinical relevance. J Mol Endocrinol (2000) 1.15
Glucosamine-derived phospholipids in Escherichia coli. Structure and chemical modification of a triacyl glucosamine 1-phosphate found in a phosphatidylglycerol-deficient mutant. J Biol Chem (1983) 1.14
Basophil recruitment and activation in inflammatory skin diseases. Allergy (2011) 1.14
Selective action of isoniazid on the synthesis of cell wall mycolates in mycobacteria. Ann N Y Acad Sci (1974) 1.13
Chemical reduction of 3-oxo and unsaturated groups in fatty acids of diphosphoryl lipid A from the lipopolysaccharide of Rhodopseudomonas sphaeroides. Comparison of biological properties before and after reduction. J Biol Chem (1991) 1.11
Purification and characterization of a novel mycolic acid exchange enzyme from Mycobacterium smegmatis. J Biol Chem (1987) 1.11
Factors affecting the bioadhesive property of tablets consisting of hydroxypropyl cellulose and carboxyvinyl polymer. Chem Pharm Bull (Tokyo) (1989) 1.10
Development of a trehalose 6,6'-dimycolate model which explains cord formation by Mycobacterium tuberculosis. Infect Immun (1993) 1.08
Signal transducer and activator of transcription 6 is essential in the induction of contact hypersensitivity. J Exp Med (2000) 1.07
Effect of hydroxypropylmethylcellulose (HPMC) on the release profiles and bioavailability of a poorly water-soluble drug from tablets prepared using macrogol and HPMC. Int J Pharm (2000) 1.06
Formulation optimization of indomethacin gels containing a combination of three kinds of cyclic monoterpenes as percutaneous penetration enhancers. J Pharm Sci (1994) 1.05
Interleukin-8 participates in angiogenesis in non-small cell, but not small cell carcinoma of the lung. Cancer Lett (1997) 1.05
Scanning electron microscopy of the H37Ra strain of Mycobacterium tuberculosis exposed to isoniazid. Antimicrob Agents Chemother (1973) 1.05
Bacteriologic investigations of unusual mycobacteria isolated from immunocompromised patients. Diagn Microbiol Infect Dis (1993) 1.04
Susceptibility of mycobacteria to rifampin. Antimicrob Agents Chemother (1972) 1.04
A pivotal role of IL-12 in Th1-dependent mouse liver injury. Int Immunol (1996) 1.03
Correlation between plasma endotoxin, plasma cytokines, and plasminogen activator inhibitor-1 activities in septic patients. World J Surg (2001) 1.02
The effect of platelet-rich plasma on the regenerative therapy of muscle derived stem cells for articular cartilage repair. Osteoarthritis Cartilage (2012) 1.02
Preparation of a stable mycobacterial tween hydrolysis test substrate. Appl Microbiol (1973) 1.01